BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30055288)

  • 1. Viewing the Eph receptors with a focus on breast cancer heterogeneity.
    Nikas I; Ryu HS; Theocharis S
    Cancer Lett; 2018 Oct; 434():160-171. PubMed ID: 30055288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EPH/ephrin profile and EPHB2 expression predicts patient survival in breast cancer.
    Husa AM; Magić Ž; Larsson M; Fornander T; Pérez-Tenorio G
    Oncotarget; 2016 Apr; 7(16):21362-80. PubMed ID: 26870995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem-like Cells from Invasive Breast Carcinoma Cell Line MDA-MB-231 Express a Distinct Set of Eph Receptors and Ephrin Ligands.
    Lucero M; Thind J; Sandoval J; Senaati S; Jimenez B; Kandpal RP
    Cancer Genomics Proteomics; 2020; 17(6):729-738. PubMed ID: 33099474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application.
    Fox BP; Kandpal RP
    Biochem Biophys Res Commun; 2004 Jun; 318(4):882-92. PubMed ID: 15147954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
    Wu Y; Du Z; Mou J; Qiu X; Chen J; Cai S; Ren D; Xiao F; Zhou G; Yuan C
    Curr Med Chem; 2023; 30(20):2340-2353. PubMed ID: 35996244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artesunate-induced Cellular Effects Are Mediated by Specific EPH Receptors and Ephrin Ligands in Breast Carcinoma Cells.
    Zadeh T; Lucero M; Kandpal RP
    Cancer Genomics Proteomics; 2022; 19(1):19-26. PubMed ID: 34949656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of eph receptor kinase activation in cancer cells by coexpressed ephrin ligands.
    Falivelli G; Lisabeth EM; Rubio de la Torre E; Perez-Tenorio G; Tosato G; Salvucci O; Pasquale EB
    PLoS One; 2013; 8(11):e81445. PubMed ID: 24348920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eph/Ephrin Signaling in the Tumor Microenvironment.
    Ieguchi K; Maru Y
    Adv Exp Med Biol; 2021; 1270():45-56. PubMed ID: 33123992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EPH/Ephrin-Targeting Treatment in Breast Cancer: A New Chapter in Breast Cancer Therapy.
    Psilopatis I; Souferi-Chronopoulou E; Vrettou K; Troungos C; Theocharis S
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex expression patterns of Eph receptor tyrosine kinases and their ephrin ligands in colorectal carcinogenesis.
    Herath NI; Spanevello MD; Doecke JD; Smith FM; Pouponnot C; Boyd AW
    Eur J Cancer; 2012 Mar; 48(5):753-62. PubMed ID: 21852108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ephs and Ephrins in malignant gliomas.
    Ferluga S; Debinski W
    Growth Factors; 2014 Dec; 32(6):190-201. PubMed ID: 25418012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eph/ephrin signaling in epithelial development and homeostasis.
    Miao H; Wang B
    Int J Biochem Cell Biol; 2009 Apr; 41(4):762-70. PubMed ID: 18761422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multifaceted roles of Eph/ephrin signaling in breast cancer.
    Kaenel P; Mosimann M; Andres AC
    Cell Adh Migr; 2012; 6(2):138-47. PubMed ID: 22568950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management.
    Psilopatis I; Pergaris A; Vrettou K; Tsourouflis G; Theocharis S
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eph receptor and ephrin function in breast, gut, and skin epithelia.
    Perez White BE; Getsios S
    Cell Adh Migr; 2014; 8(4):327-38. PubMed ID: 25482622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiling of the ephrin (EFN) and Eph receptor (EPH) family of genes in atherosclerosis-related human cells.
    Sakamoto A; Sugamoto Y; Tokunaga Y; Yoshimuta T; Hayashi K; Konno T; Kawashiri MA; Takeda Y; Yamagishi M
    J Int Med Res; 2011; 39(2):522-7. PubMed ID: 21672356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eph and ephrin signaling in mammary gland morphogenesis and cancer.
    Andres AC; Ziemiecki A
    J Mammary Gland Biol Neoplasia; 2003 Oct; 8(4):475-85. PubMed ID: 14985642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Eph receptor and ephrin expression within the human cornea and limbus.
    Hogerheyde TA; Stephenson SA; Harkin DG; Bray LJ; Madden PW; Woolf MI; Richardson NA
    Exp Eye Res; 2013 Feb; 107():110-20. PubMed ID: 23247085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles and therapeutic potentials of Ephs and ephrins in lung cancer.
    Li JJ; Xie D
    Exp Cell Res; 2013 Jan; 319(2):152-9. PubMed ID: 22960108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy.
    Liang Z; Wang X; Dong K; Li X; Qin C; Zhou H
    Biomed Res Int; 2021; 2021():5575704. PubMed ID: 33977106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.